Search research articles
Contact Us
Filters
Showing results (51-60 of 222) with videos related to
Page
of 23
Sort By:
Breast Cancer Research and Treatment
|
January 1, 1994
Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study
M Toi, T Tominaga, A Osaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 1, 1988
[Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors]
Y Nomura, H Tashiro, K Hisamatsu, et al.
Oncology Reports
|
May 19, 2011
The increase of apoptosis and the decrease of proliferation by angiogenesis inhibitor in rat mammary tumors
S Saji, M Toi, Y Yamamoto, et al.
Oncology Reports
|
May 25, 2011
Inhibition of vascular endothelial growth-factor induced cell-growth by an angiogenesis inhibitor agm-1470 in capillary endothelial-cells
M Toi, T Takayanagi, R Souma, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 1, 1996
Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells
M Toi-Scott, C L Jones, M A Kane
Histopathology
|
October 12, 2007
Diagnostic pitfall of D2-40 in adenomatosid tumour
N Kuroda, M Toi, M Hiroi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 1, 1995
Sweat gland carcinoma in a human immunodeficiency virus-infected patient
M Toi, L Kauffman, L Peterson, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 1, 1997
[The feasibility of CEF (cyclophosphamide, epirubicin, 5-FU) regimen in the adjuvant setting of primary breast cancer]
S Honda, M Toi, S Shimizu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 10, 1999
[Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline]
S Nagai, M Toi, K Kuroi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 2, 2006
Current directions for COX-2 inhibition in breast cancer
L W C Chow, W T Y Loo, M Toi
Page
of 23
Search research articles
Search
Showing results (51-60 of 222) with videos related to
Sort By:
Page
of 23
Breast Cancer Research and Treatment
|
January 1, 1994
Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study
M Toi, T Tominaga, A Osaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 1, 1988
[Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors]
Y Nomura, H Tashiro, K Hisamatsu, et al.
Oncology Reports
|
May 19, 2011
The increase of apoptosis and the decrease of proliferation by angiogenesis inhibitor in rat mammary tumors
S Saji, M Toi, Y Yamamoto, et al.
Oncology Reports
|
May 25, 2011
Inhibition of vascular endothelial growth-factor induced cell-growth by an angiogenesis inhibitor agm-1470 in capillary endothelial-cells
M Toi, T Takayanagi, R Souma, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 1, 1996
Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells
M Toi-Scott, C L Jones, M A Kane
Histopathology
|
October 12, 2007
Diagnostic pitfall of D2-40 in adenomatosid tumour
N Kuroda, M Toi, M Hiroi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 1, 1995
Sweat gland carcinoma in a human immunodeficiency virus-infected patient
M Toi, L Kauffman, L Peterson, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 1, 1997
[The feasibility of CEF (cyclophosphamide, epirubicin, 5-FU) regimen in the adjuvant setting of primary breast cancer]
S Honda, M Toi, S Shimizu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 10, 1999
[Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline]
S Nagai, M Toi, K Kuroi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 2, 2006
Current directions for COX-2 inhibition in breast cancer
L W C Chow, W T Y Loo, M Toi
Page
of 23